Fund Management At Engine No. 1 LLC Amgen Inc Transaction History

Fund Management At Engine No. 1 LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $151,524 - $188,121	693 Added 9.96%	7,649 $2.06 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $102,849 - $121,617	480 Added 7.41%	6,956 $1.54 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $135,925 - $165,670	602 Added 10.25%	6,476 $1.57 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $167,420 - $212,728	731 Added 14.21%	5,874 $1.54 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $56,339 - $63,540	-251 Reduced 4.65%	5,143 $1.16 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $144,424 - $160,719	626 Added 13.13%	5,394 $1.31 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $1.05 Million - $1.16 Million	4,768 New	4,768 $1.15 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.